Bryony J. Telford

E-cadherin loss alters cytoskeletal organization and adhesion in non-malignant breast cells but is insufficient to induce an epithelial-mesenchymal transition

Augustine Chen, Henry Beetham, Michael A. Black et al. · BMC Cancer · 2014 · 141 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +17

A Comparison of Real-Time and Endpoint Cell Viability Assays for Improved Synthetic Lethal Drug Validation

Andrew Single, Henry Beetham, Bryony J. Telford et al. · SLAS DISCOVERY · 2015 · 83 citations · Full text

Medicine, Cell Biology, Pharmacology +17

Synthetic Lethal Screens Identify Vulnerabilities in GPCR Signaling and Cytoskeletal Organization in E-Cadherin–Deficient Cells

Bryony J. Telford, Augustine Chen, Henry Beetham et al. · Molecular Cancer Therapeutics · 2015 · 36 citations · Full text

Life Sciences, Molecular Biology, Oncology +16

Multi-modal effects of 1B3, a novel synthetic miR-193a-3p mimic, support strong potential for therapeutic intervention in oncology

Bryony J. Telford, Sanaz Yahyanejad, Thijs de Gunst et al. · Oncotarget · 2021 · 36 citations · Full text

Life Sciences, Molecular Biology, Oncology +12

E-cadherin-deficient cells have synthetic lethal vulnerabilities in plasma membrane organisation, dynamics and function

Tanis Godwin, S. Thomas Kelly, Tom P. Brew et al. · Gastric Cancer · 2018 · 33 citations · Full text

Life Sciences, Cell Biology, Oncology +17